FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378173019> ?p ?o ?g. }

• W4378173019 endingPage "607" @default.
• W4378173019 startingPage "599" @default.
• W4378173019 abstract "NPM1-mutated acute myeloid leukaemia (NPM1mut AML) represents a mostly favourable/intermediate risk disease that benefits from allogeneic haematopoietic stem cell transplantation (HSCT) in case of measurable residual disease (MRD) relapse or persistence after induction chemotherapy. Although the negative prognostic role of pre-HSCT MRD is established, no recommendations are available for the management of peri-transplant molecular failure (MF). Based on the efficacy data of venetoclax (VEN)-based treatment in NPM1mut AML older patients, we retrospectively analysed the off-label combination of VEN plus azacitidine (AZA) as bridge-to-transplant strategy in 11 NPM1mut MRD-positive fit AML patients. Patients were in MRD-positive complete remission (CRMRDpos ) at the time of treatment: nine in molecular relapse and two in molecular persistence. After a median number of two cycles (range 1-4) of VEN-AZA, 9/11 (81.8%) achieved CRMRD -negative (CRMRDneg ). All 11 patients proceeded to HSCT. With a median follow-up from treatment start of 26 months, and a median post-HSCT follow-up of 19 months, 10/11 patients are alive (1 died from non-relapse mortality), and 9/10 patients are in MRDneg status. This patient series highlights the efficacy and safety of VEN-AZA to prevent overt relapse, achieve deep responses and preserve patient fitness before HSCT, in patients with NPM1mut AML in MF." @default.
• W4378173019 created "2023-05-26" @default.
• W4378173019 creator A5004376734 @default.
• W4378173019 creator A5010348935 @default.
• W4378173019 creator A5017274704 @default.
• W4378173019 creator A5018930291 @default.
• W4378173019 creator A5019480794 @default.
• W4378173019 creator A5023529754 @default.
• W4378173019 creator A5031314858 @default.
• W4378173019 creator A5031956360 @default.
• W4378173019 creator A5033473535 @default.
• W4378173019 creator A5037140934 @default.
• W4378173019 creator A5044624520 @default.
• W4378173019 creator A5049884922 @default.
• W4378173019 creator A5071926851 @default.
• W4378173019 creator A5072253025 @default.
• W4378173019 creator A5074486528 @default.
• W4378173019 creator A5079914299 @default.
• W4378173019 creator A5081465064 @default.
• W4378173019 creator A5084036614 @default.
• W4378173019 creator A5092014678 @default.
• W4378173019 date "2023-05-24" @default.
• W4378173019 modified "2023-09-27" @default.
• W4378173019 title "A venetoclax and azacitidine <scp>bridge‐to‐transplant</scp> strategy for <i>NPM1</i>‐<scp>mutated</scp> acute myeloid leukaemia in molecular failure" @default.
• W4378173019 cites W2007302457 @default.
• W4378173019 cites W2118270328 @default.
• W4378173019 cites W2153994826 @default.
• W4378173019 cites W2169046713 @default.
• W4378173019 cites W2170515966 @default.
• W4378173019 cites W2276580523 @default.
• W4378173019 cites W2419140434 @default.
• W4378173019 cites W2491126460 @default.
• W4378173019 cites W2558761368 @default.
• W4378173019 cites W2582929611 @default.
• W4378173019 cites W2952633887 @default.
• W4378173019 cites W2966178814 @default.
• W4378173019 cites W2969645972 @default.
• W4378173019 cites W2981869008 @default.
• W4378173019 cites W2982353618 @default.
• W4378173019 cites W3000515035 @default.
• W4378173019 cites W3014928753 @default.
• W4378173019 cites W3015136763 @default.
• W4378173019 cites W3030923281 @default.
• W4378173019 cites W3033312054 @default.
• W4378173019 cites W3042846071 @default.
• W4378173019 cites W3048827006 @default.
• W4378173019 cites W3092079205 @default.
• W4378173019 cites W3093003016 @default.
• W4378173019 cites W3102223894 @default.
• W4378173019 cites W3102917402 @default.
• W4378173019 cites W3135596931 @default.
• W4378173019 cites W3201366107 @default.
• W4378173019 cites W3209416216 @default.
• W4378173019 cites W4210559899 @default.
• W4378173019 cites W4283716970 @default.
• W4378173019 cites W4284884567 @default.
• W4378173019 cites W4290879107 @default.
• W4378173019 doi "https://doi.org/10.1111/bjh.18887" @default.
• W4378173019 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37226312" @default.
• W4378173019 hasPublicationYear "2023" @default.
• W4378173019 type Work @default.
• W4378173019 citedByCount "1" @default.
• W4378173019 countsByYear W43781730192023 @default.
• W4378173019 crossrefType "journal-article" @default.
• W4378173019 hasAuthorship W4378173019A5004376734 @default.
• W4378173019 hasAuthorship W4378173019A5010348935 @default.
• W4378173019 hasAuthorship W4378173019A5017274704 @default.
• W4378173019 hasAuthorship W4378173019A5018930291 @default.
• W4378173019 hasAuthorship W4378173019A5019480794 @default.
• W4378173019 hasAuthorship W4378173019A5023529754 @default.
• W4378173019 hasAuthorship W4378173019A5031314858 @default.
• W4378173019 hasAuthorship W4378173019A5031956360 @default.
• W4378173019 hasAuthorship W4378173019A5033473535 @default.
• W4378173019 hasAuthorship W4378173019A5037140934 @default.
• W4378173019 hasAuthorship W4378173019A5044624520 @default.
• W4378173019 hasAuthorship W4378173019A5049884922 @default.
• W4378173019 hasAuthorship W4378173019A5071926851 @default.
• W4378173019 hasAuthorship W4378173019A5072253025 @default.
• W4378173019 hasAuthorship W4378173019A5074486528 @default.
• W4378173019 hasAuthorship W4378173019A5079914299 @default.
• W4378173019 hasAuthorship W4378173019A5081465064 @default.
• W4378173019 hasAuthorship W4378173019A5084036614 @default.
• W4378173019 hasAuthorship W4378173019A5092014678 @default.
• W4378173019 hasBestOaLocation W43781730191 @default.
• W4378173019 hasConcept C104317684 @default.
• W4378173019 hasConcept C126322002 @default.
• W4378173019 hasConcept C143998085 @default.
• W4378173019 hasConcept C150194340 @default.
• W4378173019 hasConcept C185592680 @default.
• W4378173019 hasConcept C190727270 @default.
• W4378173019 hasConcept C2483381 @default.
• W4378173019 hasConcept C2776239401 @default.
• W4378173019 hasConcept C2777408962 @default.
• W4378173019 hasConcept C2777938653 @default.
• W4378173019 hasConcept C2778461978 @default.
• W4378173019 hasConcept C2779675984 @default.
• W4378173019 hasConcept C2779823535 @default.
• W4378173019 hasConcept C2911091166 @default.

• next